1 はじめに
2 範囲と方法論
2.1 本調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次ソース
2.3.2 二次ソース
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主な業界トレンド
5 世界のリモート患者モニタリング市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 デバイスタイプ別市場内訳
6.1 血圧モニター
6.1.1 市場動向
6.1.2 市場予測
6.2 グルコースモニター
6.2.1 市場動向
6.2.2 市場予測
6.3 心拍モニター
6.3.1 市場動向
6.3.2 市場予測
6.4 パルスオキシメーター
6.4.1 市場動向
6.4.2 市場予測
6.5 呼吸モニター
6.5.1 市場動向
6.5.2 市場予測
6.6 その他
6.6.1 市場動向
6.6.2 市場予測
7 用途別市場
7.1 癌治療
7.1.1 市場動向
7.1.2 市場予測
7.2 心血管疾患の治療とモニタリング
7.2.1 市場動向
7.2.2 市場予測
7.3 糖尿病の治療
7.3.1 市場動向
7.3.2 市場予測
7.4 睡眠障害の治療
7.4.1 市場動向
7.4.2 市場予測
7.5 体重管理とフィットネスモニタリング
7.5.1 市場動向
7.5.2 市場予測
7.6 その他
7.6.1 市場動向
7.6.2 市場予測
8 エンドユーザー別市場
8.1 病院および診療所
8.1.1 市場動向
8.1.2 市場予測
8.2 在宅医療
8.2.1 市場動向
8.2.2 市場予測
8.3 その他
8.3.1 市場動向
8.3.2 市場予測
9 地域別市場内訳
9.1 北米
9.1.1 米国
9.1.1.1 市場動向
9.1.1.2 市場予測
9.1.2 カナダ
9.1.2.1 市場動向
9.1.2.2 市場予測
9.2 アジア太平洋
9.2.1 中国
9.2.1.1 市場動向
9.2.1.2 市場予測
9.2.2 日本
9.2.2.1 市場動向
9.2.2.2 市場予測
9.2.3 インド
9.2.3.1 市場動向
9.2.3.2 市場予測
9.2.4 韓国
9.2.4.1 市場動向
9.2.4.2 市場予測
9.2.5 オーストラリア
9.2.5.1 市場動向
9.2.5.2 市場予測
9.2.6 インドネシア
9.2.6.1 市場動向
9.2.6.2 市場予測
9.2.7 その他
9.2.7.1 市場動向
9.2.7.2 市場予測
9.3 ヨーロッパ
9.3.1 ドイツ
9.3.1.1 市場動向
9.3.1.2 市場予測
9.3.2 フランス
9.3.2.1 市場動向
9.3.2.2 市場予測
9.3.3 英国
9.3.3.1 市場動向
9.3.3.2 市場予測
9.3.4 イタリア
9.3.4.1 市場動向
9.3.4.2 市場予測
9.3.5 スペイン
9.3.5.1 市場動向
9.3.5.2 市場予測
9.3.6 ロシア
9.3.6.1 市場動向
9.3.6.2 市場予測
9.3.7 その他
9.3.7.1 市場動向
9.3.7.2 市場予測
9.4 ラテンアメリカ
9.4.1 ブラジル
9.4.1.1 市場動向
9.4.1.2 市場予測
9.4.2 メキシコ
9.4.2.1 市場動向
9.4.2.2 市場予測
9.4.3 その他
9.4.3.1 市場動向
9.4.3.2 市場予測
9.5 中東およびアフリカ
9.5.1 市場動向
9.5.2 国別の市場内訳
9.5.3 市場予測
10 SWOT分析
10.1 概要
10.2 強み
10.3 弱み
10.4 機会
10.5 脅威
11 バリューチェーン分析
12 ポーターのファイブフォース分析
12.1 概要
12.2 買い手の交渉力
12.3 サプライヤーの交渉力
12.4 競争の度合い
12.5 新規参入の脅威
12.6 代替品の脅威
13 価格指標
14 競合状況
14.1 市場構造
14.2 主要企業
14.3 主要企業のプロフィール
Abbott Laboratories
AMD Global Telemedicine. Inc
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Dexcom. Inc
GE Healthcare. Inc. (Danaher Corporation)
Honeywell International. Inc
Koninklijke Philips N.V
Medtronic. Inc
Nihon Kohden Corporation
OSI Systems. Inc
Roche Holding AG

The global remote patient monitoring market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.9% during 2025-2033. The market is expanding rapidly, driven by rising geriatric population across the globe, increasing prevalence of chronic disease, rapid technological advancements, imposition of supportive government policies, and a growing demand for personalized and preventive healthcare.

Remote patient monitoring (RPM), also known as remote physiologic monitoring, refers to the use of digital technologies to collect medical and health-related data about weight, blood pressure, oxygen levels, heart rate, and electrocardiograms (ECG) from individuals in one location. It can also electronically transmit that information securely to healthcare providers in a different location. It enables healthcare professionals to maintain track of the condition of the patient without requiring them to be physically present in a healthcare facility. RPM is especially beneficial for managing chronic conditions, post-operative recovery, and elderly care.

The surging prevalence of different chronic diseases, such as diabetes, hypertension, and heart disorders, and the increasing elderly population, which is more prone to developing severe medical ailments, is bolstering the market growth around the world. Moreover, rapid digitization, considerable reliance on smartphones, growing penetration of the high-speed internet, and inflating income levels of individuals are driving the demand for RPM solutions worldwide. In addition, the rising shortage of healthcare professionals, especially in remote areas, is catalyzing the use of RPM as an alternative to traditional care methods, which allows scarce medical staff to manage more patients effectively. Apart from this, the increasing need for healthcare systems to be prepared for pandemics or similar emergencies is favoring the growth of the market. Furthermore, the growing inclination towards mobile health (m-health) applications for providing high quality virtual care and home care to patients through chatbots and real-time interactions is influencing the market positively.

Remote Patient Monitoring Market Trends/Drivers:
Increase in accessibility to healthcare services

The growing demand for RPM is largely propelled by the increasing need for healthcare accessibility. Traditional in-person visits often require patients to travel, sometimes long distances, to healthcare facilities. This can be cumbersome, particularly for elderly patients or those with chronic conditions. RPM allows patients to connect with healthcare providers without leaving the comfort of their homes, thereby making medical care more accessible. This is especially beneficial in rural areas where healthcare facilities are sparse. Mobile health apps and telemedicine services that integrate RPM are bridging this accessibility gap, which encourages more people to opt for remote healthcare options.

Rise in patient centric care

One of the factors fueling the demand for RPM is the shift towards patient-centric care. In the traditional model, healthcare is often reactive and primarily occurs in a clinical setting. RPM empowers patients to take control of their health by actively monitoring their conditions. This approach aligns with the broader trend of personalized healthcare, where treatments and care plans are tailored to individual needs. Patients can share real-time data with healthcare providers, which enables more timely and targeted interventions. The increased focus on patient-centric care is therefore driving patients and healthcare providers alike to adopt RPM solutions.

Growing regulatory support and reimbursement policies

Governmental regulations and reimbursement policies play a critical role in the adoption of RPM. In many regions, healthcare authorities are recognizing the benefits of RPM and implementing favorable policies to encourage its use. Reimbursement schemes are being adjusted to include RPM services, which makes it financially viable for healthcare providers to offer these services. This creates a favorable environment for RPM adoption, as healthcare organizations can now invest in this technology with greater confidence in financial sustainability. The alignment of regulatory frameworks with the benefits of RPM is thus acting as a catalyst for its increasing demand.

Remote Patient Monitoring Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on device type, application, and end-use.


Breakup by Device Type:

Blood Pressure Monitor
Glucose Monitor
Heart Rate Monitor
Pulse Oximeters
Respiratory Monitor
Others

Heart rate monitor dominates the market

The report has provided a detailed breakup and analysis of the market based on the device type. This includes heart rate monitor, respiratory monitor, glucose monitor, pulse oximeters, blood pressure monitor, and others. According to the report, heart rate monitor represented the largest segment. A remote heart rate monitor is a device that continuously tracks the number of heart beats per minute. It usually consists of a chest strap sensor or a wrist-based sensor that detects each heartbeat. Some advanced models may also include features like tracking irregular heartbeats or measuring other cardiac parameters.

A remote blood pressure monitor is a digital device designed to measure and record blood pressure levels from a remote location. It comprises an inflatable cuff to wrap around the arm and a monitoring unit with a digital display. The device can measure systolic and diastolic blood pressure levels.

Breakup by Application:

Cancer Treatment
Cardiovascular Diseases Treatment and Monitoring
Diabetes Treatment
Sleep Disorder Treatment
Weight Management and Fitness Monitoring
Others

Cardiovascular diseases treatment and monitoring holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cancer treatment, cardiovascular diseases treatment and monitoring, diabetes treatment, sleep disorder treatment, weight management and fitness monitoring, and others. According to the report, cardiovascular diseases treatment and monitoring accounted for the largest market share. RPM plays a significant role in the treatment and management of cardiovascular diseases. By using devices like heart rate monitors, blood pressure monitors, and even electrocardiogram (ECG) machines that can be used at home, patients and healthcare providers can track vital cardiac parameters in real-time. This constant monitoring is crucial for individuals suffering from conditions like hypertension, heart failure, or arrhythmias. It allows healthcare providers to make immediate adjustments to treatment plans, thereby potentially preventing hospital readmissions and improving patient outcomes.

Managing diabetes requires regular monitoring of blood sugar levels, which makes RPM an invaluable tool for both patients and healthcare providers. A remote glucose monitoring device is used to record blood sugar levels at multiple times throughout the day. These readings are then wirelessly transmitted to a secure database accessible to healthcare providers. The immediate availability of this data enables timely interventions, such as medication adjustments, and helps in avoiding complications like hypoglycemia or hyperglycemia.

Breakup by End-Use:

Hospitals and Clinics
Homecare Settings
Others

Hospitals and clinics dominate the market

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals and clinics, homecare settings, and others. According to the report, hospitals and clinics represented the largest segment. In hospital and clinic settings, RPM serves as an extension of traditional healthcare services, which enhances the efficiency and effectiveness of medical care. By employing RPM devices, healthcare professionals can monitor the vital signs of patients, chronic conditions, and post-operative recovery metrics even when the patients are not in the immediate care facility. This technology aids in resource allocation, which allows clinicians to prioritize patients based on the severity of their conditions, thereby streamlining hospital operations.

In homecare settings, RPM provides an invaluable service by extending the reach of healthcare services into the comfort of the patient's home. This is particularly beneficial for elderly patients, those with chronic conditions, or those in post-operative recovery who may find frequent visits to a healthcare facility cumbersome or stressful. RPM devices can monitor a wide range of health parameters including blood pressure, glucose levels, and heart rate, sending this information directly to healthcare providers for review.

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others

North America exhibits a clear dominance, accounting for the largest remote patient monitoring market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing aging population in the North America region is driving the demand for RPM solutions to manage health conditions without frequent hospital visits. Moreover, the rising awareness about the benefits of RPM solutions and services among the masses is contributing to the market growth in the region. Besides this, the growing utilization of mobile health (m-health) applications is influencing the market positively in the region.

Asia Pacific is estimated to witness stable growth, owing to integration of advanced technologies, improving internet connectivity, extensive research and development (R&D) activities, etc.

Competitive Landscape:
The leading companies are integrating artificial intelligence (AI), machine learning (ML), blockchain, and the internet of things (IoT) to enable healthcare providers to get a more comprehensive view of the health of the patients by collecting data from various sources like blood pressure monitors, glucose meters, and heart rate sensors. These advanced technologies also help analyze vast amounts of data to identify patterns, anomalies, and trends that might be missed by human observation and allow for predictive analytics, which can alert healthcare providers to potential issues before they become critical. These advancements provide a secure and unchangeable record of patient data and assist in maintaining the integrity of medical information and ensuring it is only accessible by authorized individuals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories
AMD Global Telemedicine Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Dexcom, Inc.
GE Healthcare Inc. (Danaher Corporation)
Honeywell International Inc.
Koninklijke Philips N.V.
Medtronic Inc.
Nihon Kohden Corporation
OSI Systems Inc.
Roche Holding AG

Key Questions Answered in This Report

1. What was the size of the global remote patient monitoring market in 2024?
2. What is the expected growth rate of the global remote patient monitoring market during 2025-2033?
3. What are the key factors driving the global remote patient monitoring market?
4. What has been the impact of COVID-19 on the global remote patient monitoring market?
5. What is the breakup of the global remote patient monitoring market based on the device type?
6. What is the breakup of the global remote patient monitoring market based on the application?
7. What is the breakup of the global remote patient monitoring market based on the end-use?
8. What are the key regions in the global remote patient monitoring market?
9. Who are the key players/companies in the global remote patient monitoring market?

​1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Remote Patient Monitoring Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Device Type
6.1 Blood Pressure Monitor
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Glucose Monitor
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Heart Rate Monitor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pulse Oximeters
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Respiratory Monitor
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Application
7.1 Cancer Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular Diseases Treatment and Monitoring
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diabetes Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Sleep Disorder Treatment
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Weight Management and Fitness Monitoring
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End-Use
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Homecare Settings
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AMD Global Telemedicine Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 BIOTRONIK SE & Co. KG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Boston Scientific Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Dexcom Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GE Healthcare Inc. (Danaher Corporation)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Honeywell International Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Koninklijke Philips N.V.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Medtronic Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Nihon Kohden Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 OSI Systems Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Roche Holding AG
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

*** 遠隔患者モニタリングの世界市場に関するよくある質問(FAQ) ***

・遠隔患者モニタリングの世界市場規模は？
→IMARC社は2024年の遠隔患者モニタリングの世界市場規模を17億米ドルと推定しています。

・遠隔患者モニタリングの世界市場予測は？
→IMARC社は2033年の遠隔患者モニタリングの世界市場規模を50億米ドルと予測しています。

・遠隔患者モニタリング市場の成長率は？
→IMARC社は遠隔患者モニタリングの世界市場が2025年～2033年に年平均12.9%成長すると展望しています。

・世界の遠隔患者モニタリング市場における主要プレイヤーは？
→「Abbott Laboratories, AMD Global Telemedicine, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Dexcom, Inc., GE Healthcare, Inc. (Danaher Corporation), Honeywell International, Inc., Koninklijke Philips N.V., Medtronic, Inc., Nihon Kohden Corporation, OSI Systems, Inc., Roche Holding AGなど ...」を遠隔患者モニタリング市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/